BioVaxys Technology Corp. BVAXF

BIOV~PAPILOCARE~OVOSICARE~LIBICARE GENERATE REVENUES NOW EU

[moneywagon]

Pro Health Care distributes these products and they can be bought online now. Revenues are currently flowing in EU. 
BIOV agreement with Pro Health Care........includes 2 more products already generating revenues Ovosicare and Libicare, Procare Health’s over-the-counter supplements to support fertility enhancement for late maternity or IVF processes and improve menopausal symptoms.

The vaccines, the vaccines.............those approvals will be our golden egg!!

Papilocare Clinical Trials EU started Oct 2015 and were completed 2019. See chart below

That's a ton of ....APPROVAL.....evidence for FDA to swallow!
Product already generating revenues in EU for a couple years now uhh would ya say..........

Here is the link for those interested in entire read,
please copy/paste link....

https://clinicaltrials.gov/ct2/show/NCT04002154

Study Description

 

Go to  

Brief Summary:

Phase II, exploratory, randomized, open, controlled and parallel groups clinical trial to evaluate the effectiveness of exploratory gel Papilocare in the repair of the cervico-vaginal mucosa with lesions caused by HPV. All the patients included in the study will be Randomized (1:1:1).

Condition or disease	Intervention/treatment	Phase
Human Papilloma Virus InfectionHuman Papilloma VirusCervix Lesion	Device: Papilocare vaginal gel	Not Applicable

Detailed Description:

Phase II, exploratory, randomized, open, controlled and parallel groups clinical trial to evaluate the effectiveness of exploratory gel Papilocare in the repair of the cervico-vaginal mucosa with lesions caused by HPV. All the patients included in the study will be Randomized (1:1:1) to Arm A (Papilocare schedule A), Arm B (Papilocare schedule B) and Arm C (usual clinical practice -without treatment-). Selection period of 1 month, followed by randomization and 6 months of treatment followed by a period of another 6 months without treatment. Patients will visit the site into a total of 5 visits throughout the study.

Study Design

 

Go to  

 

Study Type  :	Interventional  (Clinical Trial)
Actual Enrollment  :	134 participants
Allocation:	Randomized
Intervention Model:	Parallel Assignment
Masking:	None (Open Label)
Primary Purpose:	Treatment
Official Title:	Ensayo clnico, Aleatorizado, Abierto, de Grupos Paralelos y Con Grupo Control, Para Explorar la Eficacia Del Gel PAPILOCARE en la reparacin de la Mucosa crvico-vaginal Con Lesiones Causadas Por VPH (Ensayo Clnico PALOMA)
Actual Study Start Date  :	October 19, 2015
Actual Primary Completion Date  :	July 31, 2018
Actual Study Completion Date  :	February 28, 2019